tirzepatide is zepbound Eli Lilly Launches Self-Pay Vials of for Patients With Obesity Zepbound - Available at Chicago

For both Zepbound and Retatrutide, there are concerns about: Pancreatitis (inflammation of the pancreas) Gallbladder problems Thyroid tumors (Zepbound includes a warning about medullary thyroid carcinoma based on animal studies) Low blood sugar, especially if combined with other diabetes medications People with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 should not take these drugs

For instance, one client who lost 64 pounds (from 261 to 197 pounds) across 18 months then stalled for three months despite continuing to walk and lift

Hydration : Our team emphasizes the importance of proper hydration as part of your overall wellness

Tirzepatide has a higher potency at the GIP than at the GLP1 receptor